Cryptocurrency news

OpenAI has entered into a partnership with the laboratory that created the atomic bomb

Forklog / 11.07.2024 / 14:17
OpenAI has entered into a partnership with the laboratory that created the atomic bomb

OpenAI has announced a partnership with Los Alamos National Laboratory (LANL) to explore the use of AI in biological research.

OpenAI and Los Alamos National Laboratory announce partnership to study AI for bioscience research https://t.co/WV4XMZsHBA

— OpenAI (@OpenAI) July 10, 2024

A recent White House executive order instructed national laboratories to evaluate the capabilities of advanced AI models. OpenAI noted that artificial intelligence can greatly enhance the development of science. 

As part of the initiative, experts will explore the possibilities of using GPT-4o to perform tasks in a physical laboratory environment using multimodal capabilities such as vision and voice.

"AI is a powerful tool that can bring great benefits in the field of science, but, like any other new technology, it comes with risks," commented Nick Generous, Deputy Head of the LANL Information Systems and Modeling Group.

He noted that a new specialized group will lead the work in Los Alamos, which will help to understand and assess the risks of AI. 

Los Alamos National Laboratory was founded in 1943 as part of the Manhattan project to develop nuclear weapons led by physicist Robert Oppenheimer.

The organization is currently engaged in a wide range of scientific research, including physics, chemistry, biology, materials science and national security.

Earlier, the media learned about the hacking of OpenAI and the theft of information about the company's latest technologies. 

Recall that a new artificial intelligence model was able to detect 13 different types of cancer with an accuracy of 98.2%.

In July, Ilya Polosukhin, co-founder of Near Protocol, said that AI would not destroy humanity if it was not given such an order.

Source
Recently News

© Token Radar 2024. All Rights Reserved.
IMPORTANT DISCLAIMER: All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.